DMAC · DiaMedica Therapeutics Inc.
$6.68
-0.07 (-1.04%)
At close · Aug 14
Market Cap
$360.22M
Shares
53.93M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-11 | Second Quarter 2026 Financial Results Conference Call | Earnings call |
| 2026-05-19 | 2026 RBC Capital Markets Global Healthcare Conference Fireside Chat | Conference |
| 2026-05-07 | First Quarter 2026 Financial Results Conference Call | Earnings call |
| 2026-03-31 | Fourth Quarter 2025 Financial Results Conference Call | Earnings call |
| 2026-01-21 | Cantor KOL Webinar Highlights DM199 For PreEclampsia Looks Like A Real Drug | Event |
| 2025-09-05 | Cantor Global Healthcare Conference Fireside Chat | Conference |
| 2025-07-17 | DiaMedica's Discussion of Preeclampsia Study Part 1a Interim Results | Event |
| 2025-07-17 | Interim Phase 2 (Part 1a) Preeclampsia Data | Event |
| 2024-07-11 | White Paper: The Potential of DM199 to Treat Preeclampsia | Event |